Methods: Eight competitive male cyclists (mean ± SD; age = 26 ± 8 y; body mass = 76.7 ± 6.9 kg; VO2peak = 63 ± 4 ml.kg -1 .min -1 ) participated in a double-blind, placebo-controlled, crossover-design study in which participants ingested 70 ml beetroot juice containing ~4 mmol NO3 -(NIT) or a NO3 -depleted placebo (PLA), each for 8-days. Replicating pretreatment measures, participants undertook an incremental ramp assessment to determine VO2peak, first (VT1), and second (VT2) ventilatory thresholds on day 6 (NIT6 and PLA6), moderate-intensity cycling economy on day 7 (NIT7 and PLA7), and a 4-km time-trial on day 8 (NIT8 and PLA8). Results: Relative to PLA, 6 days of NIT supplementation produced unclear effects for VO2peak (mean ±95%CL: 1.8 ±5.5%) and VT1 (3.7 ±12.3%) and trivial effects for both VT2 (-1.0 ±3.0%) and exercise economy on day 7 (-1.0 ±1.6%). However, effects for time-trial performance time (-0.7 ±0.9%), and power (2.4 ±2.5%), on day 8 were likely beneficial. Conclusions: Despite mostly unclear outcomes for standard physiological determinants of performance, 8-days of NO3 -supplementation resulted in likely beneficial improvements to 4-km time-trial performance in well-trained male endurance cyclists.
INTRODUCTION
Dietary nitrate (NO3 -) supplementation, either through ingestion of pharmacological sodium NO3 -1,2 or naturally occurring beetroot juice 3 has generated significant interest amongst researchers, coaches and sport science practitioners, due to its marked physiological effects. 1 Specifically, NO3 -ingestion has been shown to reduce oxygen consumption during submaximal exercise, 3, 4 improve ventilatory threshold 5 and reduce the VO2 slow component and mean response time. 3 Individually and collectively, such enhancements are of interest in athletic populations given their relevance to sport performance in endurance events. 6 The performance enhancing effects of NO3 -supplementation in endurance events are well documented, 4, 7 however, ergogenic effects appear to reduce as performance trial duration increases 2, 8 and/or as athlete calibre increases. 9 The range of performance outcomes highlights the need to consider trial duration, athletic calibre and athlete type (sprint vs endurance) when interpreting the effect of NO3 -supplementation. For example, in cycling, following a single acute dose of NO3 -, moderately-trained (VO2peak 56 to 63 ml.kg.
cyclists improved performance over shorter (~6.45 to 27.30 min) 7 but not longer (40 to 137 min) duration time-trials. 2, 8 In contrast to the findings of Lansley et al 7 national level cyclists produced unclear and possibly harmful effects for 4-min time-trial mean power output (MPO) following acute doses of NO3 -. 10 Such findings suggest that acute NO3 -supplementation strategies enhance the performance of moderately trained cyclists within events of shorter -and therefore greater relative intensity -than longer duration trials. Shortduration (1-to 12-min), maximal intensity exercise leads to a rapid increase in blood acidosis 11 and although this may not directly infer a reduction in performance, 12 the stepwise reduction of nitrite (NO2 -) to nitric oxide (NO) is catalysed in more acidic and hypoxic environments 13 indicating that higher intensity exercise may enhance the effectiveness of NO3 -supplementation on performance. Improvements in mitochondrial respiration 14 and a reduction in ATP cost during muscle force production 15 are several mechanisms postulated to positively enhance measures of performance and physiology as a result of longer term (≥3 days) NO3 -supplementation. 14, 15 Based on these physiological enhancements, and given the 1.2%
improvement over longer (10-km) distance following a 6-day supplementation period, 4 it is of interest to explore whether a similar dose duration augments improvements over and above that of the 2.7% enhancement for 4-km reported by Lansley et al 7 following an acute dose in a similarly trained population. Moreover, this shorter 4-km distance may serve to produce an ideal environment for the reduction of NO2 -to NO. 13 Therefore, the aim of this study was to determine the effects of six to eight-days of beetroot juice supplementation on 4-km time-trial performance and economy in trained cyclists.
Methods

Subjects
Nine well-trained endurance male cyclists (mean ± SD; age 26 ± 8 y; body mass 76.7 ± 6.9 kg; sum of 8 skinfold 52 ± 10 mm; VO2peak 63 ± 4 ml.kg -1 .min -1 ; weekly training duration 9 ± 3 h.wk -1 ) acted as their own controls in this double-blind, placebo-controlled, crossover-design study. With ethical approval from the Auckland University of Technology research ethics committee, participants were fully informed about the study prior to providing consent. Participants were asked to maintain their usual diet but to abstain from caffeine and alcohol, 24 and 48 h prior to testing, respectively. Participants were requested to refrain from exercise the day of the test and limit exercise the day prior to no more than 2 h at moderate intensity. All experimental trials occurred at the same time of day (± 2 h) to control for biological variation. During this, and subsequent economy trials, gas-exchange and ventilatory measures were assessed using a breath-by-breath metabolic system (Metamax 3B, Cortex Biophysik, Leipzig, Germany). Calibration of the system took place prior to each test using alpha 
Beetroot Juice Supplementation
At the conclusion of the two pre-supplement testing periods, participants were placebo of identical taste, smell and appearance, supplied by the same manufacturer, consistent with previous research. 4 Participants were asked to consume the juice at a rate of 1 x 70 ml daily and, on the day of a trial, to ingest the juice 2-h before their scheduled lab appointment. The tester administering the beverage was blinded to the supplement condition.
Participants were instructed to avoid spitting, chewing gum or using antibacterial mouthwash during the supplementation interventions, as these actions are associated with a lowering of plasma/serum NO2 -levels.
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Habitual Training
Quantification of the cyclist's habitual training load (mean for duration, distance, and power) were determined during both experimental and washout phases using a calibrated wireless crank-based power meter (SRM, Julich, Germany), which was installed on each participant's bike.
Blood collection
Participants were asked to sit motionless in a reclined position for 15-min on their arrival at the laboratory. Thereafter, a venous blood sample from an antecubital vein was collected via an evacuated SST monovette tube (Becton Dickinson Biosciences). The 10 ml of extracted blood was then left to clot for 20-min before being centrifuged at 1218 x g for 10-min at 4°C (Heraeus Megafuge 16R, Thermo Scientific) as per the manufacturer's instructions. Serum was then aliquoted into micro containers and stored at -80°C for later analysis. ] levels were reported in µM, consistent with previous research using the Griess analysis method.
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Statistical Analysis
Data are presented as mean ± SD unless otherwise reported. Comparisons were made between each of the four NIT and PLA time-points for 4-km time-trial performance, economy and heart-rate using a customised analysis spread-sheet. 22 Performance data were log-transformed for analysis to reduce bias arising from non-uniformity of error, and subsequently back-transformed to obtain changes in mean and variation as percentages. To make inferences about true (population) values of the effect of NO3 -supplementation on cycling performance and incremental PPO, the uncertainty in the effect was expressed as 95% confidence limits and as likelihoods that the true value of the effect represents substantial change (harm or benefit). We present these probabilities in quantitative values and qualitative terms in preference to a statistical inference based on a null hypothesis test. An effect was deemed unclear if the chance of benefit was sufficiently high to warrant use of the treatment but the associated risk was unacceptable. Such unclear effects were identified as those with an odds ratio of benefit-harm <57, a ratio corresponding to an effect that is borderline possibly beneficial (12.5% chance of benefit) and borderline most unlikely harmful (0.25% chance of harm). 23 We assumed 1% and 0.4% as smallest worthwhile change for power and time, respectively for 4-km time-trial performance and 1% for incremental PPO. 24 The default values and qualitative terms were set at: <0.5%, most unlikely; 0. 
RESULTS
One participant withdrew due to illness during the study. Remaining participants' (n=8) self-reported adherence to supplementation was 100% for both treatment periods.
Participants reported similar daily training loads across the two supplement phases of the study (mean ± SD) for duration (PLA: 1.4 ± 1.1 h.day -1 ; NIT: 1.5 ± 0.9 h.day -1 ) or intensity (222 ± 18 W; 202 ± 14 W). No significance was detected between trials (P<0.05) for either condition, for training time (0.34) or intensity (0.14). Measurement error (CV) for time-trial to time-trial was 0.7 and 2.1% for 4-km time and power, respectively and 1.7, 4.1, 3.5, 6.5 and 11.8% for incremental peak power, VO2peak, economy, VT1 and VT2, respectively.
Pre-and post-intervention mean group outcomes are summarised in Table 1, whilst between group differences and their subsequent magnitude-based inference (MBI) are reported in Table 2 . Relative to PLA, effects of 6 days of NIT supplementation were unclear for VO2peak (mean ±95%CL: 1.8 ±5.5%), and VT1 (3.7 ±12.3%), whilst VT2 (-1.0 ±3.0%) was trivial. Effects for economy (-1.0 ±1.6%) were trivial after 7 days of NIT (Figure 1) ].
DISCUSSION
The current study aimed to determine whether NO3 -supplementation over a 6 to 8-day period would improve high-intensity cycling performance and economy in well-trained endurance cyclists. Employing identical statistical methods and terminology as previous Whereas previous findings employing a MBI approach indicated a 98.9% or very likely chance of benefit for 4-km performance, 7 we report a smaller (75%) likely beneficial outcome, alongside chances of triviality and harm of 24% and 1%, respectively ( Table 2 ).
The smallest worthwhile enhancement for cyclists competing in road time-trials has been reported to be 0.6%, 24 athletes of varying ability the present findings appear to be consistent with published outcomes in athletic outcomes utilising a 4 mmol dose of NO3 -as they relate to athletic calibre. 7, 10 In contrast to gains in performance, we report minimal differences in several physiological and performance measures, many of which have been shown to underpin performance in endurance athletes. 6 Firstly, there were unclear (mean ±95%CL: 1.8 ±5.5%) improvements in VO2peak following NO3 -supplementation whereas previous studies have reported unaltered 9 or reduced 29 VO2peak in endurance trained athletes. Secondly, there was a trivial (-1.0 ±3.0%) tendency for VT2 to decrease, which is comparable to Bescos et al 2 who
reported no change in VT2, respiratory exchange ratio (NIT 0.96; PLA 0.96) or blood lactate (NIT 7.5; PLA 7.4 mmol) following sodium NO3 -supplementation in a trained cycling
population. 2 Thirdly, similar trends were observed for measures of submaximal exercise economy (trivial and unclear) following NO3 -supplementation. This was surprising since 3 days of NO3 -supplementation has previously been shown to positively alter mitochondrial efficiency 14 by reducing the cost of ATP force production leading to improved economy. [3] [4] [5] In a similarly trained cycling population to that of our current study, Cermak et al 4 noted
improvements of 3.5% and 5.1% in economy at 45% and 65% of PPO, respectively following 6 days of NO3 -supplementation. 4 However, it should be noted that Cermak et al 4 (Table 2 ). This divergence of effects is consistent with the findings of Porcelli et al 9 where peak run speed reduced, yet 3-km run performance improved in both low-and moderately-trained cohorts following NO3 -ingestion. 9 Collectively, therefore, the findings of the current and aforementioned studies, 2, 9 suggest that despite improved time-trial performance, NO3 -supplementation has limited effect on several physiological or performance indices synonymous with endurance performance in well-trained athletes (>60 ml.kg -1 .min -1 ).
To date the majority of NO3 -related studies have analysed blood plasma using the 
CONCLUSIONS
The results of this current study add to the growing body of knowledge regarding the ergogenic effects of nitrate supplementation on high-intensity endurance performance.
Relative to placebo, daily supplementation of 70 ml beetroot juice (~4.0 mmol NO3 -) over an 8-day period had a likely beneficial enhancement on 4-km time-trial performance with nonclear outcomes for a range of physiological measures in well-trained competitive cyclists.
Future studies should explore the ergogenic effects of NO3 -on shorter duration trials given Clinical inference based on odds ratio of benefit/harm >57 where smallest beneficial change of 1% for 4-km time, mean power and incremental peak power output b Non-clinical inference based on 0.3% of CV for SEM for all other measures %95CL; add and subtract this number to the difference to obtain the 95% confidence limits for the true difference TT = time-trial; MPO = mean power output; Incr. PPO = incremental peak power output; VT1 = first ventilatory threshold; VT2 = second ventilatory threshold; HR = heart rate
